Type 2 Diabetes Mellitus Is a Risk Factor for Skeletal Muscle Loss in the Course of Dietary Treatment for Patients with Metabolic Dysfunction-associated Steatotic Liver Disease.

Intern Med · 2025 · PMC11949668 · PMID 39048367

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

showed a trendp=0.06so close (0.05 < p ≤ 0.1)

In this study, although there was no significant difference, patients over 65 years old showed a trend toward a decline in the SMI (p=0.06), suggesting that elderly people might tend to lose skeletal muscle during dietary therapy.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.